Invest in biomedical companies | Public

Fighting Disease

As humans have evolved so has our capacity to fend off and prevent diseases that threaten our wellbeing. From existing diseases like cancer—which stands to affect nearly 40% of people at some point in their lifetimes—to emerging viruses like COVID-19, public companies remain tireless in their pursuit for a cure. This theme includes disease-fighting public companies like Eli Lilly, Exelixis, Moderna, and Pfizer.

36 stocks4 etfs

Stocks

MRNA

Moderna

MRNA

BLUE

ETFs

Buy any stock with any amount of money.

Download the App
Download the app